SANDOZ POMALIDOMIDE
SANDOZ POMALIDOMIDE
Approved
DIN Number
02523973
Drug Class
Human
Market Date
Feb 28, 2023
Company
HC
Sandoz Canada, Inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02523973
AIG Number0155290001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L04AX06 POMALIDOMIDE
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
POMALIDOMIDEActive
Strength: 1 MG
Monograph: POMALIDOMIDE